The AIM Trials Fluvid RNA Vaccine study is a clinical trial evaluating a single-shot combination vaccine designed to generate a dual-virus immune response against seasonal influenza and COVID-19. The study, part of a broader industry shift toward combined respiratory vaccines, focuses on assessing safety, tolerability, and antibody generation through blood samples and monitoring. Learn more about the study on the AIM Trials website.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Fluvid: Combined Flu & COVID RNA Vaccine Study – AIM Trials
Leave a Reply